Company intelligence / Profile preview

Nemean Pharma

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

Nemean Pharma was an early-stage biotechnology company focused on developing novel small molecule therapies for cancer. Publicly available secondary sources describe the company as working on therapeutics for acute and chronic myelogenous leukemia, and as a seed-stage investment associated with Accelerator Life Science Partners. Available evidence suggests the company was based in Seattle, Washington and remained very early in development, with no clearly disclosed named clinical assets or later-stage pipeline. Corporate registry data indicate the company is no longer active.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Partnerships

Accelerator Life Science Partners

Beyond the preview

Go deeper on Nemean Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nemean Pharma.

Explore the full profile